Perpetua Medical secures a strategic milestone by resolving its dispute with Ecolab, allowing the company to restart its C10 platform operations and accelerate development of its next-generation medical cleaning technology.
The settlement with Ecolab allows Perpetua Medical's subsidiary, ES Medical, to resume production and sales of the C10 platform while initiating development of a next-generation TEE probe cleaning system. This agreement serves as a strategic milestone for the company's transition into a global product-focused entity, leveraging an existing installed base of approximately 300 systems in Scandinavia and Central Europe.
ES Medical has an installed base of approximately 300 systems, primarily located in Scandinavia and Central Europe.
The new product is expected to be introduced to the European market during the first half of 2027.
Settlement with ES-Medical resolves dispute and allows C10 production to resume, but financial terms are undisclosed.
Perpetua Medical subsidiary ES-Medical has reached a settlement with Ecolab, clearing the path to resume production and sales of its C10 TEE probe cleaning platform. The agreement also enables the development of a next-generation system, with a European market launch targeted for the first half of 2027.
The settlement allows Perpetua's subsidiary, ES-Medical, to resume production and sales of the C10 platform and provides the legal framework to develop and commercialize a new generation of TEE probe cleaning systems.